Jiangsu Unitrump Biomedical Technology

Jiangsu Unitrump Biomedical Technology is a high-tech enterprise specializing in the research, development, and industrialization of recombinant humanized collagen and other bioactive materials. The company utilizes advanced synthetic biology and protein engineering to produce high-purity collagen that mimics human physiological structures, avoiding the immunogenicity and viral risks associated with animal-derived sources. Their product portfolio spans medical aesthetics, wound care, gynecology, and orthopedics, with several products already cleared for clinical use. Unitrump operates integrated R&D and manufacturing facilities that adhere to international GMP standards to support its growing pipeline of regenerative medicine solutions. By focusing on biomimetic materials, the company aims to provide safer and more effective alternatives for tissue repair and functional restoration.